Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEDIPASVIR\SOFOSBUVIR Cause Hepatic cirrhosis? 311 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 311 reports of Hepatic cirrhosis have been filed in association with LEDIPASVIR\SOFOSBUVIR. This represents 1.3% of all adverse event reports for LEDIPASVIR\SOFOSBUVIR.

311
Reports of Hepatic cirrhosis with LEDIPASVIR\SOFOSBUVIR
1.3%
of all LEDIPASVIR\SOFOSBUVIR reports
66
Deaths
92
Hospitalizations

How Dangerous Is Hepatic cirrhosis From LEDIPASVIR\SOFOSBUVIR?

Of the 311 reports, 66 (21.2%) resulted in death, 92 (29.6%) required hospitalization, and 9 (2.9%) were considered life-threatening.

Is Hepatic cirrhosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEDIPASVIR\SOFOSBUVIR. However, 311 reports have been filed with the FAERS database.

What Other Side Effects Does LEDIPASVIR\SOFOSBUVIR Cause?

Fatigue (4,609) Headache (4,203) Nausea (1,471) Drug ineffective (1,397) Hepatitis c (1,076) Diarrhoea (1,065) Insomnia (1,021) Hepatocellular carcinoma (640) Vomiting (623) Dizziness (604)

What Other Drugs Cause Hepatic cirrhosis?

ADALIMUMAB (1,760) METHOTREXATE (1,650) ETANERCEPT (931) TOCILIZUMAB (903) RITUXIMAB (863) INFLIXIMAB (831) ABATACEPT (824) HYDROXYCHLOROQUINE (807) LEFLUNOMIDE (780) SULFASALAZINE (760)

Which LEDIPASVIR\SOFOSBUVIR Alternatives Have Lower Hepatic cirrhosis Risk?

LEDIPASVIR\SOFOSBUVIR vs LEFLUNOMIDE LEDIPASVIR\SOFOSBUVIR vs LEMBOREXANT LEDIPASVIR\SOFOSBUVIR vs LENACAPAVIR LEDIPASVIR\SOFOSBUVIR vs LENALIDOMIDE LEDIPASVIR\SOFOSBUVIR vs LENIOLISIB

Related Pages

LEDIPASVIR\SOFOSBUVIR Full Profile All Hepatic cirrhosis Reports All Drugs Causing Hepatic cirrhosis LEDIPASVIR\SOFOSBUVIR Demographics